Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Neoplasm

Neoplasm

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Neoplasm

16 trials tracked for Neoplasm.

16Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 3 Phase 1 10 Other / NA 3
  1. Phase 2 Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy Completed
  2. Phase 2 Study of ADI-PEG 20 in Patients With Advanced Melanoma Completed
  3. Phase 2 Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors Completed
  4. Phase 1 Study of an Experimental New Drug, PPARγ Agonist Taken by Mouth by Participants With Advanced or Metastatic Cancer Completed
  5. Phase 1 A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors Completed
  6. Phase 1 Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma Completed
Show 10 more trials
  1. Phase 1 A Study of Olaratumab in Japanese Participants With Advanced Cancer Completed
  2. Phase 1 A Study of LY2835219 in Participants With Cancer Completed
  3. Phase 1 A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours) Completed
  4. Phase 1 Study of Dalotuzumab (MK-0646) in Adults With Solid Tumors (MK-0646-009) Completed
  5. Phase 1 A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC) Completed
  6. Phase 1 Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies Completed
  7. Phase 1 A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. Completed
  8. N/A A Phase II Study of Spinal Radiosurgery Completed
  9. N/A Family-supported Smoking Cessation for Chronically Ill Veterans Completed
  10. N/A Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions Completed

Showing the 16 most-cited and recently-updated of 16 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Boron neutron capture therapy combined with immunotherapy may enhance anti-tumor response and transform the tumor microenvironment
Allergy & Immunology Sys. Review
Boron neutron capture therapy combined with immunotherapy may enhance anti-tumor response and transform the tumor microenvironment Novel insights into the clinical translation of BNCT combined with immunotherapy
This narrative review discusses the potential of combining Boron neutron capture therapy (BNCT) with immunotherapy. The authors suggest this…
A narrative review suggests combining Boron neutron capture therapy with immunotherapy may boost anti-tumor responses and change the tumor e…
Frontiers May 29, 2026